HHS cancels over $700 million in funding for Moderna’s flu pandemic vaccines
Moderna was notified its funding to research and license vaccines set to protect against future flu pandemics -- including bird flu -- has been terminated by the Department of Health and Human Services (HHS).
The funding was originally signed with the Biden administration and consisted of an initial contract of over $150 million and a second contract of nearly $600 million.
It comes while Moderna announced positive results from their early trial of an mRNA bird flu vaccine.
Antibody titers, a sign of immune protection, increased nearly 45-fold in those vaccinated. A total of 300 adults participated in the trial.
At least 70 people in the U.S. have been infected with bird flu after the virus was found in cows for the first time early last year. One person has died since. Health officials say the current risk of the virus is low, but are monitoring for further spread or any mutations that would change that assessment.
Moderna noted they would "explore alternatives for late-stage development and manufacturing" of their bird flu vaccine program.
-ABC News’ Youri Benadjaoud







